$AVAH News

UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $14

Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript

CORRECTION: Aveanna Healthcare FY2026 Revenue expected to be more than $2.680B vs $2.625B Est

Aveanna Healthcare Q2 Adj. EPS $0.22 Beats $0.17 Estimate, Sales $670.483M Beat $638.619M Estimate

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?

Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors

Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call

Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy?

Aveanna (AVAH) Stock Looks To Trade At A Discount To Fair Value

Aveanna Healthcare (AVAH): Best Future Stocks to Buy Under $10

Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $11

Are You Looking for a Top Momentum Pick? Why Aveanna Healthcare (AVAH) is a Great Choice

Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock

Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $9.5

Aveanna Healthcare (AVAH) is a Great Momentum Stock: Should You Buy?

Aveanna (AVAH) Is Attractively Priced Despite Fast-paced Momentum

Why Aveanna (AVAH) Might be Well Poised for a Surge

Does Aveanna (AVAH) Have the Potential to Rally 29.01% as Wall Street Analysts Expect?